Clinical Trial

Tumor-informed MRD for Non-small Cell Lung Cancer

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to evaluate the clinical utility of a personalized, WES-informed MRD detection approach in patients with early-stage non-small cell lung cancer, with a focus on its association with postoperative recurrence and prognosis, as well as its ability to predict recurrence earlier than imaging.
Trial Details
NCT Number NCT07596433
Lead Sponsor Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Conditions Non-small Cell Lung Cancer (NSCLC)
Enrollment 450 participants
Start Date 2022-02-18
Primary Completion 2026-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-19